News from astrazeneca A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 22, 2020, 09:45 ET AstraZeneca y el Instituto Nacional de Cardiología "Ignacio Chávez" suscriben alianza en beneficio de pacientes con Insuficiencia Cardiaca

Actualmente, las enfermedades cardiovasculares constituyen la primera causa de mortalidad en el mundo y en México, suelen tener su origen en la...


Oct 19, 2020, 17:20 ET El asma grave no controlada es la principal causa de hospitalización

El asma es una afección crónica causada por la inflamación de las vías respiratorias que afecta a 339 millones de personas en el mundo. Datos del...


Oct 06, 2020, 15:36 ET Câncer de Mama: O que você precisa saber sobre um dos cânceres mais comum entre as mulheres

O câncer de mama, apesar de ser bastante falado, ainda é uma doença que carrega muita desinformação. Caracterizado pelo crescimento desenfreado das...


Sep 09, 2020, 17:33 ET Suscriben Alianza AstraZeneca y nebulizadores NEBUCOR, en beneficio de los pacientes con asma

Ante las crecientes estadísticas del asma en México y las necesidades actuales de las personas con esta enfermedad, AstraZeneca firmó una alianza con ...


Sep 02, 2020, 13:17 ET Setembro Vermelho: a importância da conscientização das doenças cardiovasculares

O Setembro Vermelho é celebrado em homenagem ao Dia Mundial do Coração, reservado para a conscientização acerca da saúde deste órgão tão importante...


Aug 07, 2020, 18:30 ET Insuficiência cardíaca: como identificar e tratar a doença crônica

tríade sintomática da insuficiência cardíaca que leva o paciente a procurar o médico envolve a falta de ar, a fadiga extrema e o inchaço nas pernas. ...


May 04, 2020, 13:41 ET Dia da Asma: Doença que afeta mais de 6 milhões de pessoas no país pode ser responsável por piores quadros da COVID-19

Organizado pela Iniciativa Global Contra a Asma, a GINA - Global Initiative for Asthma, em inglês -, a primeira terça-feira de maio é responsável por ...


Feb 21, 2020, 11:07 ET Especialistas impulsan el abordaje multidisciplinario e integral de las enfermedades cardio-renal-metabólicas

Las enfermedades cardiovasculares, renales y metabólicas (como la diabetes) lideran las causas de muerte a nivel mundial, al ocasionar alrededor de...


Jan 16, 2020, 11:09 ET Educational Lung Cancer Event Coming to Houston to Raise Awareness of State's High Rate of Lung Cancer

In an effort to show how advances in science are being harnessed in the fight against lung cancer, The LungXperience, an educational exhibit...


Apr 18, 2018, 07:06 ET US FDA Approves TAGRISSO® (osimertinib) As 1st-Line Treatment For EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO® (osimertinib) for the 1st-line treatment of...


Feb 16, 2018, 11:11 ET US FDA APPROVES IMFINZI® (DURVALUMAB) FOR UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER

AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has...


Jan 10, 2018, 08:00 ET BYDUREON® BCise™ Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes

AstraZeneca today announced that BYDUREON® BCise™ (exenatide extended-release) injectable suspension 2mg is now available in pharmacies across the...


Nov 14, 2017, 18:02 ET FASENRA (benralizumab) Receives US FDA Approval For Severe Eosinophilic Asthma

AstraZeneca (NYSE: AZN) and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration...


Oct 31, 2017, 14:54 ET US FDA APPROVES ASTRAZENECA'S CALQUENCE® (acalabrutinib) FOR ADULT PATIENTS WITH PREVIOUSLY-TREATED MANTLE CELL LYMPHOMA

AstraZeneca and its hematology research and development center of excellence, Acerta Pharma, today announced that the US Food and Drug Administration ...


May 01, 2017, 15:52 ET AstraZeneca's IMFINZI™ (Durvalumab) Receives US FDA Accelerated Approval For Previously Treated Patients With Advanced Bladder Cancer

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has...


Apr 11, 2016, 09:29 ET Eficacia de ceftazidime-avibactam en el tratamiento de bacterias Gram-negativas resistentes a múltiples fármacos

Este comunicado de prensa se ha redactado en inglés. Las traducciones al alemán, francés y español las suministra PRNewswire como servicio a clientes ...


Apr 10, 2016, 08:56 ET L'analyse poolée de sept études cliniques révèle une efficacité constante de la ceftazidime-avibactam dans le traitement des bactéries Gram négatif multi-résistantes

Ce communiqué de presse a été écrit en anglais. Les traductions en allemand, français et espagnol ont été réalisées par PR Newswire pour le confort...


Apr 10, 2016, 08:54 ET Gepoolte Analyse von sieben klinischen Studien ergibt konstante Wirksamkeit von Ceftazidim-Avibactam bei der Behandlung von multiresistenten gramnegativen Bakterien

Diese Pressemitteilung wurde auf Englisch verfasst. Übersetzungen auf Deutsch, Französisch und Spanisch werden von PRNewswire für unsere...


Mar 10, 2016, 07:00 ET AstraZeneca Partners With Dr. Phil To Launch The "ON IT" Movement For People With Type 2 Diabetes

When Dr. Phil McGraw was diagnosed with type 2 diabetes 25 years ago, he made a commitment to get on – and stay on – a healthy path. Now, AstraZeneca ...


Nov 13, 2015, 11:25 ET TAGRISSO™ (osimertinib) (AZD9291) Approved By The US FDA As Treatment For Patients With EGFR T790M Mutation-Positive Metastatic Non-Small Cell Lung Cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO™ (osimertinib) (AZD9291) 80mg once-daily tablets for ...


Sep 25, 2015, 09:52 ET The National Forum for Heart Disease & Stroke Prevention and AstraZeneca Ask You to Join in Raising Awareness of Cholesterol Health with World Heart Day Thunderclap

Cardiovascular disease is a leading cause of death, globally. In the United States, every 33 seconds someone dies of heart disease, making it the...


Sep 03, 2015, 05:49 ET US FDA Approves Expanded Indication For BRILINTA To Include Long-Term Use In Patients With A History Of Heart Attack

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved BRILINTA® (ticagrelor) tablets at a new 60mg dose to be used...


Jun 08, 2015, 09:24 ET Cholesterol Awareness Initiative Makes Its Move Across America

AstraZeneca (NYSE: AZN) is on the road in support of cholesterol education. Earlier this year, the company launched the "Make Your Move Across...


Apr 27, 2015, 03:00 ET Positive Phase-III-Ergebnisse für zwei Antibiotika, Zinforo™▼ und Prüfpräparat Ceftazidime-avibactam, auf führendem Kongress für Infektionskrankheiten vorgestellt

Diese Pressemitteilung wurde auf Englisch verfasst. Übersetzungen auf Deutsch, Französisch und Spanisch werden von PRNewswire für unsere...


Apr 27, 2015, 03:00 ET Résultats de phase III positifs pour deux antibiotiques, Zinforo™▼ et l'expérimental Ceftazidime-Avibactam, présentés à l'occasion d'une conférence de premier plan sur les maladies infectieuses

Ce communiqué de presse a été écrit en anglais. Les traductions en allemand, français et espagnol ont été réalisées par PR Newswire pour le confort...